Lessons learned from a new survey about what motivates and retains patients in rare disease trials could have much wider applications in other clinical trials, according to those who conducted […]
“The FDA doesn’t call to ask if it’s a good time for an inspection,” Neala Lane, Associate Director, Quality Improvement Office at Indiana University told attendees of ACRP’s Virtual 2021 […]
Moffitt Cancer Center is among more than 75 sites participating in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community […]
As clinical research professionals, we understand the value of patient-donated data. Clinical trials can be time-consuming and sometimes onerous for patients, so we owe it to patients to use their […]
“Focus on building quality into the clinical trial process through proactive compliance rather than ‘inspecting’ quality in,” David Burrow, director of the Office of Scientific Investigations within the Office of […]